BE905219A - CEPHALOSPORIN SALTS AND INJECTABLE COMPOSITIONS. - Google Patents
CEPHALOSPORIN SALTS AND INJECTABLE COMPOSITIONS.Info
- Publication number
- BE905219A BE905219A BE07217010A BE217010A BE905219A BE 905219 A BE905219 A BE 905219A BE 07217010 A BE07217010 A BE 07217010A BE 217010 A BE217010 A BE 217010A BE 905219 A BE905219 A BE 905219A
- Authority
- BE
- Belgium
- Prior art keywords
- injectable compositions
- alpha
- methyl
- mixture
- sulfuric acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Les sels d'addition cristallins des acides sulfurique, dinitrique, monochlorhydrate, dichlorhydrate et les di- et sesqui-orthosphosphate du 7-(alpha- (2-aminothiazol-4-yl) -alpha-(Z) -méthoxyiminoacétamidol)-3- ((1-méthyl-1-pyrrolidinio) méthyl)-3-céphem-4-carboxylate sont stables meme à des températures élevées. Ainsi, on prépare le sel d'addition cristallin de l'acide sulfurique en formant un mélange de (a) au moins un équivalent molaire d'acide sulfurique avec (b) un ion dipolaire en quantité telle qu'il soit présent dans le mélange à une concentration supérieure à 25 mg/ml, on provoque la cristallisation, on sépare les cristaux, on lave et on sèche.The crystalline addition salts of sulfuric, dinitric, monohydrochloride, dihydrochloride and the di- and sesqui-orthosphosphate of 7- (alpha- (2-aminothiazol-4-yl) -alpha- (Z) -methoxyiminoacetamidol) -3- ((1-methyl-1-pyrrolidinio) methyl) -3-cephem-4-carboxylate are stable even at elevated temperatures. Thus, the crystalline addition salt of sulfuric acid is prepared by forming a mixture of (a) at least one molar equivalent of sulfuric acid with (b) a dipolar ion in an amount such that it is present in the mixture. at a concentration above 25 mg / ml, crystallization is carried out, the crystals are separated, washed and dried.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76223585A | 1985-08-05 | 1985-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE905219A true BE905219A (en) | 1987-02-04 |
Family
ID=25064475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE07217010A BE905219A (en) | 1985-08-05 | 1986-08-04 | CEPHALOSPORIN SALTS AND INJECTABLE COMPOSITIONS. |
Country Status (34)
| Country | Link |
|---|---|
| JP (1) | JPH0615548B2 (en) |
| KR (1) | KR930003121B1 (en) |
| AR (1) | AR243894A1 (en) |
| AT (1) | AT390957B (en) |
| AU (1) | AU597262B2 (en) |
| BE (1) | BE905219A (en) |
| CA (1) | CA1284994C (en) |
| CH (1) | CH675581A5 (en) |
| CS (2) | CS276849B6 (en) |
| CY (1) | CY1614A (en) |
| DD (2) | DD254941A5 (en) |
| DE (1) | DE3626375A1 (en) |
| DK (1) | DK162053C (en) |
| EG (1) | EG18003A (en) |
| ES (1) | ES2002112A6 (en) |
| FI (1) | FI84484C (en) |
| FR (1) | FR2585705B1 (en) |
| GB (1) | GB2179936B (en) |
| GR (1) | GR862055B (en) |
| HK (1) | HK99691A (en) |
| HU (1) | HU196602B (en) |
| IE (1) | IE59222B1 (en) |
| IL (1) | IL79608A (en) |
| IT (1) | IT1197067B (en) |
| LU (2) | LU88574I2 (en) |
| MY (1) | MY102212A (en) |
| NL (1) | NL8601991A (en) |
| OA (1) | OA08672A (en) |
| PT (1) | PT83134B (en) |
| SE (1) | SE469633B (en) |
| SG (1) | SG79791G (en) |
| SU (1) | SU1516013A3 (en) |
| YU (1) | YU45793B (en) |
| ZA (1) | ZA865842B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4883868A (en) * | 1984-12-27 | 1989-11-28 | Banyu Pharmaceutical Co., Ltd. | 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives |
| US4959469A (en) * | 1984-12-27 | 1990-09-25 | Banyu Pharmaceutical Company, Ltd. | Crystalline cephalosporin compounds |
| US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
| US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
| US4808617A (en) * | 1985-12-18 | 1989-02-28 | Bristol-Myers Company | Lyophilized or precipitated cephalosporin zwitterion and salt combination |
| EP0321562B1 (en) * | 1987-06-25 | 1993-11-24 | Banyu Pharmaceutical Co., Ltd. | Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation |
| JPH02101081A (en) * | 1988-10-08 | 1990-04-12 | Meiji Seika Kaisha Ltd | Crystalline dihydrochloride of cephalosporin derivative and production thereof |
| CA2011116C (en) * | 1989-03-06 | 1999-11-16 | Murray A. Kaplan | Lyophilized bmy-28142 dihydrochloride for parenteral use |
| CA2101571A1 (en) * | 1992-09-08 | 1994-03-09 | Elizabeth A. Garofalo | Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof |
| EP0638573A1 (en) * | 1993-08-10 | 1995-02-15 | Lucky Ltd. | Crystalline hydrates of cephalosporin and process for preparation thereof |
| EP1699804B1 (en) | 2003-12-23 | 2008-02-06 | Sandoz Gmbh | Process for production of intermediates for use in cefalosporin synthesis |
| WO2008056221A2 (en) * | 2006-11-06 | 2008-05-15 | Orchid Chemicals & Pharmaceuticals Limited | Crystalline sulfate salt of cephalosporin antibiotic |
| DE102012101680A1 (en) * | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Pharmaceutical preparation containing an antiviral dihydroquinazoline derivative |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55151588A (en) * | 1979-05-14 | 1980-11-26 | Takeda Chem Ind Ltd | Preparation of cephalosporin salt crystal |
| US4406899A (en) * | 1982-03-04 | 1983-09-27 | Bristol-Myers Company | Cephalosporins |
| CA1213882A (en) * | 1982-03-04 | 1986-11-12 | Jun Okumura | Cephalosporins |
| US4525473A (en) * | 1983-03-30 | 1985-06-25 | Bristol-Myers Company | Cephalosporins |
| DE3419015A1 (en) * | 1984-05-22 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | METHOD FOR PRODUCING CEPHALOSPORINES |
| GB8424692D0 (en) * | 1984-10-01 | 1984-11-07 | Glaxo Group Ltd | Chemical compounds |
| GB2165245B (en) * | 1984-10-01 | 1988-05-25 | Glaxo Group Ltd | Chemical compounds |
-
1986
- 1986-07-28 CA CA000514766A patent/CA1284994C/en not_active Expired - Lifetime
- 1986-07-28 FR FR8610892A patent/FR2585705B1/en not_active Expired
- 1986-07-29 AR AR86304717A patent/AR243894A1/en active
- 1986-07-30 AU AU60694/86A patent/AU597262B2/en not_active Expired
- 1986-07-31 YU YU137186A patent/YU45793B/en unknown
- 1986-08-01 FI FI863155A patent/FI84484C/en not_active IP Right Cessation
- 1986-08-01 IE IE207886A patent/IE59222B1/en not_active IP Right Cessation
- 1986-08-04 JP JP61183288A patent/JPH0615548B2/en not_active Expired - Lifetime
- 1986-08-04 CH CH3117/86A patent/CH675581A5/de not_active IP Right Cessation
- 1986-08-04 GB GB8618989A patent/GB2179936B/en not_active Expired
- 1986-08-04 LU LU88574C patent/LU88574I2/en unknown
- 1986-08-04 CS CS903570A patent/CS276849B6/en unknown
- 1986-08-04 SE SE8603308A patent/SE469633B/en not_active IP Right Cessation
- 1986-08-04 DK DK371886A patent/DK162053C/en not_active IP Right Cessation
- 1986-08-04 PT PT83134A patent/PT83134B/en unknown
- 1986-08-04 BE BE07217010A patent/BE905219A/en not_active IP Right Cessation
- 1986-08-04 CS CS865827A patent/CS276717B6/en unknown
- 1986-08-04 IT IT21409/86A patent/IT1197067B/en active Protection Beyond IP Right Term
- 1986-08-04 LU LU86540A patent/LU86540A1/en unknown
- 1986-08-04 NL NL8601991A patent/NL8601991A/en not_active Application Discontinuation
- 1986-08-04 DE DE19863626375 patent/DE3626375A1/en not_active Ceased
- 1986-08-04 IL IL79608A patent/IL79608A/en not_active IP Right Cessation
- 1986-08-04 GR GR862055A patent/GR862055B/en unknown
- 1986-08-04 ZA ZA865842A patent/ZA865842B/en unknown
- 1986-08-04 SU SU864027914A patent/SU1516013A3/en active
- 1986-08-05 AT AT0211086A patent/AT390957B/en not_active IP Right Cessation
- 1986-08-05 KR KR1019860006445A patent/KR930003121B1/en not_active IP Right Cessation
- 1986-08-05 ES ES8600872A patent/ES2002112A6/en not_active Expired
- 1986-08-05 HU HU863376A patent/HU196602B/en unknown
- 1986-08-05 OA OA58918A patent/OA08672A/en unknown
- 1986-08-05 DD DD86293433A patent/DD254941A5/en unknown
-
1987
- 1987-09-29 MY MYPI87002279A patent/MY102212A/en unknown
-
1988
- 1988-03-30 DD DD88314213A patent/DD268395A5/en unknown
-
1989
- 1989-08-04 EG EG489/86A patent/EG18003A/en active
-
1991
- 1991-10-02 SG SG797/91A patent/SG79791G/en unknown
- 1991-12-05 HK HK996/91A patent/HK99691A/en not_active IP Right Cessation
-
1992
- 1992-07-10 CY CY1614A patent/CY1614A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE905219A (en) | CEPHALOSPORIN SALTS AND INJECTABLE COMPOSITIONS. | |
| ES2012948A6 (en) | Cefepime cephalosporin salts | |
| MA21722A1 (en) | DERIVATIVES OF 2 - AMINOPYRIMIDINONES USEFUL IN PARTICULAR AS ANTAGONISTS OF NEUROTRANSMITTERS AND PROCESS FOR THEIR PREPARATION. | |
| FI102753B1 (en) | A process for the preparation of novel therapeutically useful substituted thiazolyl and pyridinyl derivatives | |
| JPS5334795A (en) | Cephalosporin derivatives and their preparation | |
| SU1706390A3 (en) | Method for preparation n-/(4- [(indolo - 3,2-b) chinoline - 10-yl)amino]-3-methoxyphenyl) amide hydrochloride | |
| DE69120013D1 (en) | Solid lactulose | |
| ID964B (en) | COMPOUNDS 4- (5,6,7,8-TETRAHIDROIMIDAZO [1,5-a] PYRIDIN-5-IL) HEMIHIDRAT | |
| DE69032733D1 (en) | Lyophilized dihydrochloride salt of 7- [alpha- (2-aminothiazol-4-yl) alpha (Z) methoxyiminoacetamide] -3 - [(1-methyl-1-pyrrolidinium) methyl] -3-cephem-4-carboxylic acid | |
| DE3160328D1 (en) | Crystalline salts of a cephalosporin, their preparation and pharmaceutical compositions containing them | |
| GB8802622D0 (en) | Chemical compound | |
| ES8102142A1 (en) | 33cephem compound* its salt* their preparation* and preventive and remedy for microbism comprising thema active constituent | |
| JPS5533500A (en) | 3,7-disubstituted-3-cephem-4-carboxylic acid, its salt, their preparation, and preventive and remedy for microbism | |
| ES8503199A1 (en) | Anthelmintics. | |
| MY116452A (en) | Cephalosporin salts and injectable compositions | |
| DK391883D0 (en) | Be stated in. TO PREPARE A CRYSTALLIZED ACID ADDITION SALT OF 7- (2- (2-AMINO-4-THIAZOLYL) -2-METHOXYIMINOACETAMIDO) -2-CARBOXY-3- (2- (5,6-DIOXO-4-FORMYLMETHYL-1,4) 5,6-TETRAHYDRO-1,2,4-TRIAZIN-3-YL) -THIOVINYL-8-OXO-5-THIA-1-AZABICYCLO (4.2.0) -2-OCTEN (SYNISOMER, FORM E) | |
| JPS6466191A (en) | Novel cephalosporin derivative and antibacterial | |
| ES8706158A1 (en) | Process for preparing cephalosporin compounds. | |
| JPS5283862A (en) | 7-methoxycephalosporin derivatives | |
| BE901218A (en) | CHLOROCEFADROXIL MONOHYDRATE. | |
| KR890701595A (en) | Crystalline Cephalosporin Compounds, Preparations thereof and Intermediates thereof | |
| JPS56127391A (en) | Cephem compound, its salt, their preparation, and preventive and remedy for bacteriosis containing the same | |
| JPS5663947A (en) | Bemzamide derivative | |
| JPS57131795A (en) | Novel cephem compound and salt thereof, preparation of the same and preventing agent and remedy for microbism | |
| SU1282506A1 (en) | 2-(3′,4′,5′-trimethoxyphenyl)-1-methylimidazo[4, 5-c]pyridine hydrochloride possessing spasmolytic and hypotensive activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CCPA | Application for a supplementary protection certificate |
Free format text: 094C0018; 094C0018 |
|
| CCPV | Grant of a supplementary protection certificate |
Free format text: 094C0018, EXPIRES 20080727 |
|
| RE20 | Patent expired |
Owner name: *BRISTOL-MYERS SQUIBB CY Effective date: 20060804 |
|
| CCRE | Expiry of a supplementary protection certificate |
Free format text: PRODUCT NAME: CEFEPIME DICHLORHYDRATE MONOHYDRATE; NATIONAL REGISTRATION NO/DATE: 203 IS 240 F 12 19940606; FIRST REGISTRATION: FR 558 101.3 19930727 Spc suppl protection certif: 94C0018 Filing date: 19941205 Expiry date: 20060804 Extension date: 20080727 |